怎样才能充分控制高血压?当前的考虑因素

Donald E. Casey Jr. MD, MPH, MBA , Alexander J. Blood MD, MSc , Stephen D. Persell MD, MPH , Daniel Pohlman MD , Jeff D. Williamson MD, MHS
{"title":"怎样才能充分控制高血压?当前的考虑因素","authors":"Donald E. Casey Jr. MD, MPH, MBA ,&nbsp;Alexander J. Blood MD, MSc ,&nbsp;Stephen D. Persell MD, MPH ,&nbsp;Daniel Pohlman MD ,&nbsp;Jeff D. Williamson MD, MHS","doi":"10.1016/j.mayocpiqo.2024.06.001","DOIUrl":null,"url":null,"abstract":"<div><p>An estimated 45% of adult Americans currently have high blood pressure (HBP). Effective blood pressure (BP) control is essential for preventing major adverse events from cardiovascular and other vascular-related diseases, such as chronic kidney disease, stroke and dementia. A large and growing number of medical professional societies, health care organizations, and governmental agencies have now endorsed a clinical practice guideline-based target for adequate control of HBP to a systolic BP of less than 130 mm Hg. However, adequate BP control to this goal has been recently estimated to be as low as 30%. The first and most important steps to guide effective BP control include accurate, standardized BP measurement and formal assessment of overall atherosclerotic cardiovascular disease risk. In addition to appropriate pharmacologic treatment, optimal BP management must also include multifaceted guideline-directed lifestyle modifications. High-quality evidence now supports effective uniform HBP control that is consistently achievable for most of people from diverse backgrounds. This can be accomplished through identification and prioritization of social determinants of health enabled by shared decision making that is delivered via team-based care. Such integrated approaches can have a substantial impact for simultaneously reducing several major modifiable atherosclerotic cardiovascular disease risk factors. Hence, moving the “Big Needle” of improved overall cardiovascular, kidney, and brain health of the US population must no longer be solely relegated to primary care and will require a major and coordinated reprioritization of capital and evidence-based human resource allocations by all health care stakeholder organizations.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454824000377/pdfft?md5=0a4bf6d7fbd90fcf31e1a47f2f7e4386&pid=1-s2.0-S2542454824000377-main.pdf","citationCount":"0","resultStr":"{\"title\":\"What Constitutes Adequate Control of High Blood Pressure? Current Considerations\",\"authors\":\"Donald E. Casey Jr. MD, MPH, MBA ,&nbsp;Alexander J. Blood MD, MSc ,&nbsp;Stephen D. Persell MD, MPH ,&nbsp;Daniel Pohlman MD ,&nbsp;Jeff D. Williamson MD, MHS\",\"doi\":\"10.1016/j.mayocpiqo.2024.06.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>An estimated 45% of adult Americans currently have high blood pressure (HBP). Effective blood pressure (BP) control is essential for preventing major adverse events from cardiovascular and other vascular-related diseases, such as chronic kidney disease, stroke and dementia. A large and growing number of medical professional societies, health care organizations, and governmental agencies have now endorsed a clinical practice guideline-based target for adequate control of HBP to a systolic BP of less than 130 mm Hg. However, adequate BP control to this goal has been recently estimated to be as low as 30%. The first and most important steps to guide effective BP control include accurate, standardized BP measurement and formal assessment of overall atherosclerotic cardiovascular disease risk. In addition to appropriate pharmacologic treatment, optimal BP management must also include multifaceted guideline-directed lifestyle modifications. High-quality evidence now supports effective uniform HBP control that is consistently achievable for most of people from diverse backgrounds. This can be accomplished through identification and prioritization of social determinants of health enabled by shared decision making that is delivered via team-based care. Such integrated approaches can have a substantial impact for simultaneously reducing several major modifiable atherosclerotic cardiovascular disease risk factors. Hence, moving the “Big Needle” of improved overall cardiovascular, kidney, and brain health of the US population must no longer be solely relegated to primary care and will require a major and coordinated reprioritization of capital and evidence-based human resource allocations by all health care stakeholder organizations.</p></div>\",\"PeriodicalId\":94132,\"journal\":{\"name\":\"Mayo Clinic proceedings. Innovations, quality & outcomes\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2542454824000377/pdfft?md5=0a4bf6d7fbd90fcf31e1a47f2f7e4386&pid=1-s2.0-S2542454824000377-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mayo Clinic proceedings. Innovations, quality & outcomes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2542454824000377\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mayo Clinic proceedings. Innovations, quality & outcomes","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2542454824000377","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

据估计,目前有 45% 的成年美国人患有高血压 (HBP)。有效控制血压对于预防心血管和其他血管相关疾病(如慢性肾病、中风和痴呆症)引起的重大不良事件至关重要。目前,越来越多的医学专业协会、医疗保健组织和政府机构已经批准了一项基于临床实践指南的目标,即充分控制 HBP,使收缩压低于 130 mm Hg。然而,据最近估计,充分控制血压达到这一目标的比例低至 30%。指导有效控制血压的第一步也是最重要的一步包括准确、标准化的血压测量和对整体动脉粥样硬化性心血管疾病风险的正式评估。除了适当的药物治疗外,最佳血压管理还必须包括多方面的指导性生活方式调整。目前,高质量的证据支持有效统一地控制 HBP,这对大多数不同背景的人来说都是可以持续实现的。要做到这一点,就必须识别健康的社会决定因素并确定其优先次序,并通过以团队为基础的护理提供共同决策。这种综合方法对同时减少几种主要的可改变的动脉粥样硬化性心血管疾病风险因素具有重大影响。因此,改善美国人口整体心血管、肾脏和大脑健康的 "大针 "不能再仅仅局限于初级保健,而需要所有医疗保健利益相关者组织对资本和循证人力资源的分配进行重大而协调的重新优先排序。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
What Constitutes Adequate Control of High Blood Pressure? Current Considerations

An estimated 45% of adult Americans currently have high blood pressure (HBP). Effective blood pressure (BP) control is essential for preventing major adverse events from cardiovascular and other vascular-related diseases, such as chronic kidney disease, stroke and dementia. A large and growing number of medical professional societies, health care organizations, and governmental agencies have now endorsed a clinical practice guideline-based target for adequate control of HBP to a systolic BP of less than 130 mm Hg. However, adequate BP control to this goal has been recently estimated to be as low as 30%. The first and most important steps to guide effective BP control include accurate, standardized BP measurement and formal assessment of overall atherosclerotic cardiovascular disease risk. In addition to appropriate pharmacologic treatment, optimal BP management must also include multifaceted guideline-directed lifestyle modifications. High-quality evidence now supports effective uniform HBP control that is consistently achievable for most of people from diverse backgrounds. This can be accomplished through identification and prioritization of social determinants of health enabled by shared decision making that is delivered via team-based care. Such integrated approaches can have a substantial impact for simultaneously reducing several major modifiable atherosclerotic cardiovascular disease risk factors. Hence, moving the “Big Needle” of improved overall cardiovascular, kidney, and brain health of the US population must no longer be solely relegated to primary care and will require a major and coordinated reprioritization of capital and evidence-based human resource allocations by all health care stakeholder organizations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Mayo Clinic proceedings. Innovations, quality & outcomes
Mayo Clinic proceedings. Innovations, quality & outcomes Surgery, Critical Care and Intensive Care Medicine, Public Health and Health Policy
自引率
0.00%
发文量
0
审稿时长
49 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信